Treatment offers new lifeline for people who get most ill from Covid-19 – study
A study has found an antiviral drug offers a new lifeline for people who get sickest from Covid-19 (Joe Giddens/PA)
People who get the most ill from Covid-19 could be offered a new lifeline with the first antiviral drug shown to save lives in patients admitted to hospital, researchers have said.
The Recovery trial demonstrated that the antibody combination developed by Regeneron reduced the risk of death when given to patients with severe Covid-19, who had not mounted a natural antibody response of their own.




